5th Circuit Affirms Summary Judgment For FDA In GLP-1 Drug Shortage Delisting Cases
NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals, in separate unpublished decisions, affirmed summary judgment for the U.S. Food and Drug Administration in challenges to the agency’s removal of...To view the full article, register now.
Already a subscriber? Click here to view full article